These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Tiazofurin-induced selective depression of NAD content in hepatoma 3924A.
    Author: Liepnieks JJ, Faderan MA, Lui MS, Weber G.
    Journal: Biochem Biophys Res Commun; 1984 Jul 18; 122(1):345-9. PubMed ID: 6743337.
    Abstract:
    The NAD content in hepatoma 3924A was approximately 40% of that in the liver of ACI/N rats bearing this hepatoma. Treatment of tumor-bearing rats with tiazofurin decreased NAD pools in the hepatoma, but no change was apparent in the liver. In a dose-response study, injection of varying amounts of the drug decreased NAD pools in the hepatoma in a dose-dependent fashion. In time-sequence studies, a single drug dose (200 mg/kg) depressed NAD pools in the hepatoma from 2 to 24 h after injection to approximately 50% of control at the lowest point before returning to control range at 48 h. The tiazofurin-induced depletion of NAD pools in the hepatoma to approximately 20% of that of normal liver might play a role in the anti-cancer action and toxicity of this drug.
    [Abstract] [Full Text] [Related] [New Search]